Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 3, 2008, Pages 311-317

  Krebs, D W ^a,e   Chi, B H ^a,b   Mulenga, Y ^c   Morris, M ^a   Cantrell, R A ^a,b   Mulenga, L ^a   Levy, J ^a   Sinkala, M ^d   Stringer, J S A ^a,b  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Project Concern International   (Zambia)

^d MINISTRY OF HEALTH   (Zambia)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY MASS; CAREGIVER; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; ZAMBIA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APPOINTMENTS AND SCHEDULES; ATTITUDE TO HEALTH; CD4 LYMPHOCYTE COUNT; COMMUNITY HEALTH SERVICES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; TREATMENT REFUSAL; ZAMBIA;

EID: 41349113382     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701594776     Document Type: Article

References (29)

1. Anglaret, X., Toure, S., Gourvellec, G., Tchehy, A., Zio, L., Zaho, M., et al. (2004). Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes, 35, 320-323.
2. Bangsberg, D.R., Perry, S., Charlebois, E.D., Clark, R.A., Roberston, M., Zolopa, A.R., et al. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
3. Bekker, L.G., Myer, L., Orrell, C., Lawn, S., & Wood, R. (2006). Rapid scale-up of a community-based HIV treatment service: Programme performance over three consecutive years in Guguletu, South Africa. South African Medical Journal, 96, 315-320.
4. Berg, M.B., Safren, S.A., Mimiaga, M.J., Grasso, C., Boswell, S., & Mayer, K.H. (2005). Non-adherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care, 17, 902-907.
5. Braitstein, P., Brinkhof, M.W., Dabis, F., Schechter, M., Boulle, A., Miotti, P., et al. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet, 367, 817-824.
6. Chi, B.H., Chansa, K., Gardner, M.O., Sangi-Haghpeykar, H., Goldenberg, R.L., Sinkala, M., et al. (2004). Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: A survey of maternity-based health care providers in Zambia. International Journal of STD & AIDS, 15, 685-690.
7. Fusco, H., Hubschman, T., Mweeta, V., Chi, B.H., Levy, J., Sinkala, M., et al. (2005). Electronic patient tracking supports rapid expansion of HIV care and treatment in resource-constrained settings (Abstract MoPe11.2C37). Paper presented at the 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janiero, Brazil.
8. Gill, C.J., Hamer, D.H., Simon, J.L., Thea, D.M., & Sabin, L.L. (2005). No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS, 19, 1243-1249.
9. Hatchett, L.A., Kaponda, C.P.N., Chihana, C.N., Chilemba, E., Nyando, M., & Simwaka, A. (2004). Health-seeking patterns for AIDS in Malawi. AIDS Care, 16, 827-833.
10. Ickovics, J.R., & Meade, C.S. (2002). Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care, 14, 309-318.
11. Kaplan, W.A. (2006). Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Globalization & Health, 2, 9.
12. Lucas, G.M., Chaisson, R.E., & Moore, R.D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81-87.
13. Mills, E.J., Nachega, J.B., Buchan, I., Orbinski, J., Attaran, A., Singh, S., et al. (2006). Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. Journal of the American Medical Association, 296, 679-690.
14. Mqhayi, M., Dalal, R., Wing, J., & Venter, W. (2006). Causes for defaulting ART in an urban clinic (Abstract 550). Paper presented at the 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO.
15. Mukherjee, J.S. (2006). The PIH guide to the community-based treatment of HIV in resource-poor settings, second edition. Available at: http://www.pih.org/inforesources/HIV/PIH_HIV_Handbook_Toronto_edition.pdf (accessed 28 June, 2007).
16. Nachega, J.B., Hislop, M., Dowdy, D.W., Lo, M., Omer, S.B., Regensberg, L., et al. (2006). Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. Journal of Acquired Immune Deficiency Syndromes, 43, 78-84.
17. Nieuwkerk, P.T., Sprangers, M.A., Burger, D.M., Hoetelmans, R.M., Hugen, P.W., Danner, S.A., et al. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Archives of Internal Medicine, 161, 1962-1968.
18. Orrell, C., Bangsberg, D.R., Badri, M., & Wood, R. (2003). Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS, 17, 1369-1375.
19. Puccio, J.A., Belzer, M., Olson, J., Martinez, M., Salata, C., Tucker, D., et al. (2006). The use of cell phone reminder calls for assisting HIV-infected adolescents and young adults to adhere to highly active antiretroviral therapy: A pilot study. AIDS Patient Care and STDs, 20, 438-444.
20. Rastegar, D.A., Fingerhood, M.I., & Jasinski, D.R. (2003). Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care, 15, 231-237.
21. Sethi, A.K., Celentano, D.D., Gange, S.J., Moore, R.D., & Gallant, J.E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112-1118.
22. Stringer, J.S., Zulu, I., Levy, J., Stringer, E.M., Mwango, A., Chi, B.H., et al. (2006). Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes. Journal of the American Medical Association, 296, 782-793.
23. Thierman, S., Chi, B.H., Levy, J.W., Sinkala, M., Goldenberg, R.L., & Stringer, J.S. (2006). Individual-level predictors for HIV testing among antenatal attendees in Lusaka, Zambia. American Journal of the Medical Sciences, 332, 13-17.
24. US Department of Health and Human Services. (2005). Code of Federal Regulations: Title 45, Part 46, Office of Human Research Protections. Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm (accessed 5 March, 2006).
25. Wainberg, M.A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279, 1977-1983.
26. Weidle, P.J., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W., et al. (2006). Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet, 368, 1587-1594.
27. Weiser, S., Wolfe, W., Bangsberg, D., Thior, I., Gilbert, P., Makhema, J., et al. (2003). Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. Journal of Acquired Immune Deficiency Syndromes, 34, 281-288.
28. Wood, E., Hogg, R.S., Yip, B., Moore, D., Harrigan, P.R., & Montaner, J.S. (2006). Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts >or =200 cells/microl. AIDS, 20, 1117-1123.
29. World Health Organization (2006). Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: Towards universal access. Available at: http://www.who.int/hiv/pub/guidelines/adult/en/ index.html (accessed 15 August, 2006).